Benzofuran

Benzofuran

SCHEMBL5035535

CCN(CC)CCOc1ccccc1.c1ccc2occc2c1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.54
HTT P42858 2/20 0.54
CYP1A2 P05177 1/20 0.54
LTA4H P09960 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
SIGMAR1 Q99720 6/20 0.51
PTPN1 P18031 1/20 0.47
EBP Q15125 3/20 0.47
ESR1 P03372 3/20 0.47
KCNH2 Q12809 2/20 0.47
CHRM2 P08172 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
CHRM1 P11229 2/20 0.47
PTGS1 P23219 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
DRD3 P35462 2/20 0.47
HTR6 P50406 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12610941 0.82 CYP2D6 (0.74) CYP2D6HTTCYP1A2LTA4HCYP2C9
SCHEMBL1405290 0.82 CYP2D6 (0.74) CYP2D6HTTCYP1A2LTA4HCYP2C9
Hydrochloric Acid SCHEMBL10505479 0.80 CYP2D6 (0.72) CYP2D6HTTCYP1A2LTA4HCYP2C9
Bromide SCHEMBL1173547 0.80 CYP2D6 (0.72) CYP2D6HTTCYP1A2LTA4HCYP2C9
Benzofuran SCHEMBL29288365 0.74 AGXT (0.46) LTA4HKCNH2KCNA3TSHR
SCHEMBL22224170 0.74 ALDH1A1 (0.63) CYP2D6HTTCYP1A2LTA4HCYP2C9
SCHEMBL6676718 0.73 LTA4H (0.62) CYP2D6HTTCYP1A2LTA4HCYP2C9
SCHEMBL9706125 0.73 EBP (0.72) CYP2D6HTTCYP1A2LTA4HCYP2C9
Benzofuran SCHEMBL5035533 0.72 KCNA3 (0.33) KCNH2ADRA2ACHRM5ADRA2BHTR2A
Benzofuran SCHEMBL28188884 0.72 CA4 (0.54) CYP2D6CYP1A2LTA4HCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664267-B2 Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide) ACADEMIC PHARMACEUTICALS INCORPORATED (US) 2014-03-04 US disclosed
US-20080255229-A1 Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide) ACADEMIC PHARMACEUTICALS INCORPORATED 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255229-A1 Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide) TNNC1, NPPA, TNNI3 CYP2D6 106/4885HTT 3989/4885CYP1A2 422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.